EUVIMEDObjevte EUVIMED
Open access

TTK Overexpression as a Prognostic Indicator and Immune Modulator in Kidney Renal Clear Cell Carcinoma

Anuradha Singh, Naga Rajiv Lakkaniga iD

Molecular Carcinogenesis · 2026-08 · 65 (8) · 989-1005

DOI: 10.1002/mc.70132 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2026-05-26. Written by Anuradha Singh and 1 co-authors. Institution: Department of Chemistry and Chemical Biology, Indian Institute of Technology (Indian School of Mines), Dhanbad, jharkhand, India. Major MEDLINE topics: Kidney Neoplasms, Protein Serine-Threonine Kinases, Carcinoma, Renal Cell, Biomarkers, Tumor. 62 references. The full text is freely available in PubMed Central. Funded by: Science and Engineering Research Board (SERB), Government of India.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Kidney renal clear cell carcinoma (KIRC) is a highly aggressive and heterogeneous malignancy characterized by poor clinical outcomes and limited reliable prognostic biomarkers. This study performed a comprehensive bioinformatic analysis to evaluate the clinical and biological significance of threonine–tyrosine kinase (TTK/Mps1) in KIRC. Transcriptomic analyses demonstrated significant overexpression of TTK in tumor tissues, which was strongly associated with advanced stage, metastatic progression, and reduced patient survival. Multivariate regression confirmed TTK as an independent prognostic indicator with high diagnostic accuracy. Network and enrichment analyses revealed that TTK is embedded within a tightly connected mitotic regulatory module, primarily involving spindle assembly checkpoint signaling, G2/M transition control, and chromosome segregation processes. Key co‐expressed genes included BUB1, CCNB1, CDK1, and CENPF, indicating a coordinated proliferative program. Pathway analysis further showed strong positive associations with oncogenic cell‐cycle signatures and negative correlations with metabolic pathways. Immune profiling indicated that elevated TTK expression correlates with increased immune infiltration and is associated with alterations in the tumor microenvironment. Collectively, these findings suggest that TTK is associated with prognosis and may serve as a potential biomarker in KIRC, with its therapeutic relevance requiring further investigation.

Subjects

MeSH terms (MEDLINE)

Kidney NeoplasmsProtein Serine-Threonine KinasesCarcinoma, Renal CellBiomarkers, TumorProtein-Tyrosine KinasesCell Cycle ProteinsHumansPrognosisGene Expression Regulation, NeoplasticGene Expression ProfilingTumor Microenvironment

Author keywords

TCGAbioinformaticsbiomarkerskidney renal clear cell carcinomathreonine–tyrosine kinase

Substances

Protein Serine-Threonine KinasesBiomarkers, TumorProtein-Tyrosine KinasesTTK protein, humanCell Cycle Proteins

Authors and institutions

  • Department of Chemistry and Chemical Biology, Indian Institute of Technology (Indian School of Mines), Dhanbad, jharkhand, India.

ORCID profiles: Naga Rajiv Lakkaniga

Funding

  • Science and Engineering Research Board (SERB), Government of India

Cite

APA

Singh, A., & Lakkaniga, N. R. (2026). TTK Overexpression as a Prognostic Indicator and Immune Modulator in Kidney Renal Clear Cell Carcinoma. Molecular Carcinogenesis, 65(8), 989-1005. https://doi.org/10.1002/mc.70132

Vancouver

Singh A, Lakkaniga NR. TTK Overexpression as a Prognostic Indicator and Immune Modulator in Kidney Renal Clear Cell Carcinoma. Molecular Carcinogenesis. 2026;65(8):989-1005. doi:10.1002/mc.70132

BibTeX
@article{Singh2026,
  author = {Singh, Anuradha and Lakkaniga, Naga Rajiv},
  title = {TTK Overexpression as a Prognostic Indicator and Immune Modulator in Kidney Renal Clear Cell Carcinoma},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {8},
  pages = {989--1005},
  doi = {10.1002/mc.70132}
}
Start for free →